10 completed, 1 active not recruiting, 1 terminated, 1 unknown. 14 Phase 2, 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 14 | Completed 10, Active not recruiting 1, Terminated 1, Unknown 1, Withdrawn 1 |
| Phase 3 | 3 | Completed 1, Terminated 1, Unknown 1 |
Follow Solumedrol: new trials by email Literature Review of Solumedrol trials Research Report on Solumedrol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Prospective Evaluation of Peri-Operative Glucocorticoid Use in the Management of Cervicofacial Infections of Odontogenic Origin Methylprednisolone - Odontogenic Infection of Jaw (Disorder) | Phase 2 / Phase 3 | Completed | University of Manitoba | 29 | 2022-06-22 | 2023-07-21 |
| Tocilizumab in Active Moderate-severe Graves' Orbitopathy Tocilizumab 20 Mg/mL Intravenous Solution, MethylPREDNISolone Injectable Solution - Graves Ophthalmopathy | Phase 2 | Completed | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | 56 | 2019-12-18 | 2026-10-23 |
| Belatacept Pilot Study in Lung Transplantation Immunosuppression in Lung Transplantation Belatacept, Tacrolimus, ATG - Lung Transplant Rejection, Antibody-mediated Rejection | Phase 2 | Completed | Washington University School of Medicine | 27 | 2019-12-17 | 2022-11-25 |
| Intrathecal Rituximab in Progressive Multiple Sclerosis Rituximab IT, methylprednisolone IV, Rituximab IV - Multiple Sclerosis, Chronic Progressive, Nervous System Diseases | Phase 2 | Completed | Centre Hospitalier de PAU | 10 | 2015-11-30 | 2019-10-03 |
| Effects and Safety of Infusion of Low-Doses of Methylprednisolone in Early ALI and ARDS in Children Methylprednisolone Arm, Sterile Saline Arm - Acute Lung Injury, Acute Respiratory Distress Syndrome | Phase 2 | Withdrawn | Universidade Federal do Rio de Janeiro | 2014-01-01 | 2020-07-10 | |
| Immunosuppression in Amyotrophic Lateral Sclerosis (ALS) Basiliximab, Methylprednisolone, Prednisone - Amyotrophic Lateral Sclerosis (ALS) | Phase 2 | Completed | Emory University | 31 | 2013-10-01 | 2017-11-06 |
| Oxidant Status and Effect of Antioxidant in Immune Thrombocytopenia Antox tablets(Mepaco), drug therapy for ITP - Immune Thrombocytopenia | Phase 2 / Phase 3 | Unknown | Ain Shams University | 100 | 2013-03-01 | 2013-01-09 |
| Efficacy Study of Adrenocorticotropin Hormone to Treat Multiple Sclerosis (MS) Relapses After Sub-responding to an Initial 3 Day Course of Intravenous (IV) Methylprednisolone Methylprednisolone, ACTH, IV placebo - Multiple Sclerosis | Phase 2 / Phase 3 | Terminated | Neurologique Foundation, Inc. | 30 | 2009-10-01 | 2016-03-22 |
| Tandem Stem Cell Transplantation for Non-Hodgkin's Lymphoma Stem cell infusion, TLI, Anti-thymocyte globulin - Lymphoma, Non-Hodgkin | Phase 2 | Active not recruiting | Washington University School of Medicine | 18 | 2009-05-05 | 2026-02-02 |
| Phase 2 Study of Autologous Followed by Nonmyeloablative Allogeneic Transplantation Using TLI & ATG Autologous peripheral blood stem cells (auto-PBSC) transplantation, Allogeneic peripheral blood stem cells (allo-PBSC) transplantation, Filgrastim - Transplantation, Homologous, Transplantation, Autologous | Phase 2 | Completed | Stanford University | 9 | 2009-05-01 | 2017-10-20 |
| Intrapleural Methylprednisolone Injection for Multiple Organ Failure With Acute Respiratory Distress Syndrome conventional ECMO with intravenous steroid, solumedrol - Acute Respiratory Distress Syndrome (ARDS), Multiple Organ Failure | Phase 2 | Completed | National Taiwan University Hospital | 29 | 2005-06-01 | 2011-08-26 |
| Phase 2 Trial of Prophylactic Rituximab Therapy for Prevention of CGVHD Total lymphoid irradiation, Rituximab, Anti-thymoglobulin, rabbit (ATG, rabbit ATG) - Leukemia, Mast-Cell, Mantle-cell Lymphoma | Phase 2 | Completed | Stanford University | 36 | 2005-06-01 | 2017-11-28 |
| Modified Hyper-CVAD (Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone) Program for Acute Lymphoblastic Leukemia Rituximab, Cyclophosphamide (CTX), Doxorubicin - Leukemia, Acute Lymphoblastic Leukemia | Phase 2 | Completed | M.D. Anderson Cancer Center | 220 | 2002-11-01 | 2020-12-03 |
| Allogeneic Transplantation From Related Haploidentical Donors non-myeloablative hematopoietic cell transplantation, Anti-Thymocyte Globulin, Cyclosporine - Blood Cancer, Leukemia | Phase 2 | Completed | Stanford University | 16 | 2000-08-01 | 2019-12-04 |
Leukemia (2) · Respiratory Distress Syndrome (2) · Acute Lung Injury (1) · Amyotrophic Lateral Sclerosis (1) · Graft vs Host Disease (1) · Graves Disease (1) · Graves Ophthalmopathy (1) · Hematologic Neoplasms (1) · Hodgkin Disease (1) · Hyperthyroidism (1) · Leukemia, Mast-Cell (1) · Lymphoma (1) · Lymphoma, Mantle-Cell (1) · Lymphoma, Non-Hodgkin (1) · Multiple Myeloma (1)
Stanford University (3) · Washington University School of Medicine (2) · Ain Shams University (1) · Centre Hospitalier de PAU (1) · Emory University (1) · Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico (1) · M.D. Anderson Cancer Center (1) · National Taiwan University Hospital (1) · Neurologique Foundation, Inc. (1) · Universidade Federal do Rio de Janeiro (1) · University of Manitoba (1)
United States (8) · Brazil (1) · Canada (1) · Egypt (1) · France (1) · Italy (1) · Taiwan (1)
Arnaldo P Barbosa (1) · Christina N Fournier, MD (1) · Daniel Kantor, MD (1) · David Miklos (1) · Fernanda Lima (1) · Jonathan D Glass, MD (1) · Keith Stockerl-Goldstein, MD (1) · Maria Clara M Barbosa (1) · Mario MS Salvi, MD (1) · Mickael Bonnan, MD (1) · Mohsen S Elalfy, professor (1) · Pei-Ming Huang, MD, MS (1) · Ramsey R Hachem, MD (1) · Robert Lowsky (1)
PMID 22563089, PMID 28422025, PMID 29308669, PMID 37899481
P01CA049605 (1)